International Therapeutics, Inc. v. McGraw-Edison Co.

721 F.2d 488, 37 U.C.C. Rep. Serv. (West) 774, 1983 U.S. App. LEXIS 14354
CourtCourt of Appeals for the Fifth Circuit
DecidedDecember 19, 1983
Docket82-1257
StatusPublished
Cited by22 cases

This text of 721 F.2d 488 (International Therapeutics, Inc. v. McGraw-Edison Co.) is published on Counsel Stack Legal Research, covering Court of Appeals for the Fifth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
International Therapeutics, Inc. v. McGraw-Edison Co., 721 F.2d 488, 37 U.C.C. Rep. Serv. (West) 774, 1983 U.S. App. LEXIS 14354 (5th Cir. 1983).

Opinion

POLITZ, Circuit Judge:

In this Texas diversity action International Therapeutics, Inc. (Therapeutics) sought damages from McGraw-Edison Company (McGraw) for breach of contract. After submission on special interrogatories, the jury found that as of April 22, 1976, Therapeutics and McGraw had a course of dealing which McGraw terminated without reasonable notice, causing damages to Therapeutics of $60,000. The district court denied McGraw’s motion for judgment n.o.v. Concluding that the record contains inadequate evidence to support the jury’s finding of a course of dealing between the parties as of April 22, 1976, we reverse and render judgment in favor of McGraw.

Facts

In 1972, McGraw acquired the G.W. Murphy Tool Co. which was manufacturing a medical device known as a mechanical per-cussor. The percussors were used in the treatment of individuals suffering with asthma, cystic fibrosis and other pulmonary diseases, and were composed of an outer casing, produced from a mold provided by Therapeutics, and an interior mechanism which was part of a sabre saw. Murphy began selling the percussors to Therapeutics in 1970. When McGraw acquired Murphy, it continued this sales arrangement.

Under their verbal agreement, McGraw received periodic forecasts of Therapeutics’ needs and manufactured percussors in anticipation of those needs. Therapeutics placed specific purchase orders from time to time. No advance payment or prior security was required of Therapeutics. Instead, it was merely obliged to pay within 30 to 90 days of receipt of the goods, occasionally receiving a discount for payment within ten days.

The agreement was honored until the latter part of 1975 when business relations between the parties began to deteriorate. By December, Therapeutics was seriously in arrears. Purchase order payments had not been made within the traditional 30 to 90 day period; indeed, Therapeutics had failed to make payment for more than 200 days. On December 12, 1975, McGraw gave Therapeutics written notice that it would not ship the pending orders until it received Therapeutics’ financial statement. Therapeutics failed to submit the required statement. On January 16,1976, McGraw wrote Therapeutics advising that because of its failure to provide the financial information, all outstanding purchase orders were being canceled.

The letter of January 16, 1976, presaged by the letter of December 12, 1975, ended the contractual arrangement between McGraw and Therapeutics. When the parties resumed business activity in February, the scenario had changed. McGraw required the posting of a letter of credit and required payment in advance before accepting and shipping new orders. The prepayment requirement was to continue until the delinquent balance was paid in full.

By March 1976, Therapeutics was aware of production changes at McGraw, understood that McGraw had only a limited number of units in inventory, and was aware of MeGraw’s position that the sale of subse- ■ quently manufactured units would be subject to significantly different contractual provisions including a higher unit price. Discussions were undertaken. By letter dated April 22, 1976, McGraw informed Therapeutics that it would enter into subsequent sales only if Therapeutics agreed in writing to specific conditions, including the purchase of 5,000 percussors annually, with a guaranteed quarterly purchase of 1,250 units, an increased unit price which was to be payable in 60 days, and Therapeutics’ acquisition of insurance protection for McGraw. No agreement was reached. Therapeutics filed the instant action claiming that by the letter of April 22, 1976 *491 McGraw had terminated the contractual relationship then existing between them without giving reasonable notice. Specifically, Therapeutics claimed that from 1970 until April 22, 1976 McGraw was contractually bound by a course of dealing to provide Therapeutics with an indefinite supply of percussors. Therapeutics contended that McGraw’s termination without notice caused it to lose profits.

Several issues are presented on appeal but only one need be addressed, the threshold issue whether the record contains evidence of a course of dealing extant on April 22, 1976, sufficient to support the jury’s verdict. The standard against which we measure the evidence was announced in Boeing v. Shipman, 411 F.2d 365, 374-75 (5th Cir.1969) (en banc):

On motions for directed verdict and for judgment notwithstanding the verdict the Court should consider all of the evidence — not just that evidence which supports the non-mover’s case — but in the light and with all reasonable inferences most favorable to the party opposed to the motion. If the facts and inferences point so strongly and overwhelmingly in favor of one party that the Court believes that reasonable men could not arrive at a contrary verdict, granting of the motions is proper. On the other hand, if there is substantial evidence opposed to the weight that reasonable and fair-minded men in the exercise of impartial judgment might reach different conclusions, the motions should be denied, and the case submitted to the jury. A mere scintilla of evidence is insufficient to present a question for the jury. The motions for directed verdict and judgment n.o.v. should not be decided by which side has the better of the case, nor should they be granted only when there is a complete absence of probative facts to support a jury verdict. There must be a conflict in substantial evidence to create a jury question. However, it is the function of the jury as the traditional finder of the facts, and not the Court, to weigh conflicting evidence and inferences, and determine the credibility of witnesses.

Analysis

The Uniform Commercial Code (UCC), adopted in Texas as the Business and Commerce Code of Texas, recognizes that parties may form contracts by formal offer and acceptance or by conduct which implicitly establishes a contractual relationship. Such conduct includes the parties’ “course of dealing” which is defined by UCC § 1-205(1): 1

A course of dealing is a sequence of previous conduct between the parties to a particular transaction which is fairly to be regarded as establishing a common basis of understanding for interpreting their expressions and other conduct.

The emphasis is on a sequence of events; a single transaction cannot constitute a course of dealing.

Contracts may be for a stated period or may be indefinite. UCC § 2-309(2) 2 provides for the duration of the latter:

Where the contract provides for successive performances but is indefinite in duration it is valid for a reasonable time but unless otherwise agreed may be terminated at any time by either party.

Under § 2-309(3) 3 this termination “requires that reasonable notification be received by the other party.”

In addition to mutual dissolution, the UCC envisions two separate and discrete methods for bringing a contract to an end, termination and cancellation. In defining the two in § 2-106, 4

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Jonibach Management Trust v. Wartburg Enterprises, Inc.
136 F. Supp. 3d 792 (S.D. Texas, 2015)
C.R. Pittman Construction Co., Inc.
Armed Services Board of Contract Appeals, 2015
M.M. Silta, Inc. v. Cleveland Cliffs, Inc.
572 F.3d 532 (Eighth Circuit, 2009)
Trans-Tec Asia v. M/V HARMONY CONTAINER
435 F. Supp. 2d 1015 (C.D. California, 2005)
L&M Enterprises, Inc. v. Bei Sensors & Systems Co.
231 F.3d 1284 (Tenth Circuit, 2000)
Heating & Air Specialists, Inc. v. Jones
180 F.3d 923 (Eighth Circuit, 1999)
Nos. 98-1809, 98-2047
180 F.3d 923 (Eighth Circuit, 1999)
Remco Equipment Sales, Inc. v. Manz
952 S.W.2d 437 (Court of Appeals of Tennessee, 1997)
Sonfast Corp. v. York International Corp.
875 F. Supp. 1088 (M.D. Pennsylvania, 1994)
Genmoora Corp. v. Moore Business Forms, Inc.
939 F.2d 1149 (Fifth Circuit, 1991)
Underground Construction Co. v. United States
35 Cont. Cas. Fed. 75,604 (Court of Claims, 1988)
USX Corp. v. Union Pacific Resources Co.
753 S.W.2d 845 (Court of Appeals of Texas, 1988)
City of Phoenix v. Great Western Bank & Trust
712 P.2d 966 (Court of Appeals of Arizona, 1985)

Cite This Page — Counsel Stack

Bluebook (online)
721 F.2d 488, 37 U.C.C. Rep. Serv. (West) 774, 1983 U.S. App. LEXIS 14354, Counsel Stack Legal Research, https://law.counselstack.com/opinion/international-therapeutics-inc-v-mcgraw-edison-co-ca5-1983.